欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号FI/H/0923/001
药品名称Azulvig 12,5 mg/pump actuation
活性成分
    • SILDENAFIL CITRATE 25.0 mg/ml
剂型Oral suspension
上市许可持有人Nutra Essential OTC, S.L. C/ La Granja 1 Alcobendas 28108 Madrid Spain
参考成员国 - 产品名称Finland (FI)
互认成员国 - 产品名称
    • Norway (NO)
    • Sweden (SE)
    • Denmark (DK)
许可日期2017/12/11
最近更新日期2017/12/12
药物ATC编码
    • G04BE03 sildenafil
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Other Generic application Art 10.3 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
    市场状态Withdrawn(注:已撤市)
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase